Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 4/20 | 0.47 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.33 |
| ▸ | FBP1 | P09467 | 2/20 | 0.32 |
| ▸ | KDM4A | O75164 | 1/20 | 0.32 |
| ▸ | PHGDH | O43175 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21087584 | 0.96 | MGLL (0.53) | MGLLHRH3FBP1KDM4APHGDH | |
| SCHEMBL19058030 | 0.81 | — | — | |
| SCHEMBL21087586 | 0.74 | MGLL (0.55) | MGLLPHGDHALDH1A1ALDH2 | |
| SCHEMBL22773554 | 0.72 | — | — | |
| SCHEMBL18583236 | 0.72 | — | — | |
| SCHEMBL23084778 | 0.69 | — | — | |
| SCHEMBL22296130 | 0.69 | — | — | |
| SCHEMBL18583119 | 0.67 | — | — | |
| SCHEMBL5965068 | 0.67 | MGLL (0.92) | MGLL | |
| SCHEMBL10959852 | 0.67 | MGLL (0.53) | MGLL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10615456-B2 | Additive for nonaqueous electrolyte solutions, nonaqueous electrolyte solution and electricity storage device | SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) | 2020-04-07 | — | — | US | disclosed |
| US-10573929-B2 | — | — | 2020-02-25 | — | — | US | disclosed |
| US-20190181499-A1 | ADDITIVE FOR NONAQUEOUS ELECTROLYTE SOLUTIONS, NONAQUEOUS ELECTROLYTE SOLUTION AND ELECTRICITY STORAGE DEVICE | SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) | 2019-06-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10615456-B2 | Additive for nonaqueous electrolyte solutions, nonaqueous electrolyte solution and electricity storage device | SLC9A1, SLC26A3, SCNN1A | MGLL 3002/4885HRH3 481/4885FBP1 2797/4885 |
| US-10573929-B2 | — | SLC26A3, SLC9A1, CLIC1 | MGLL 3319/4885HRH3 495/4885FBP1 1956/4885 |
| US-20190181499-A1 | ADDITIVE FOR NONAQUEOUS ELECTROLYTE SOLUTIONS, NONAQUEOUS ELECTROLYTE SOLUTION AND ELECTRICITY STORAGE DEVICE | SLC9A1, SLC26A3, SCNN1A | MGLL 3002/4885HRH3 481/4885FBP1 2797/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.